This authoritative review synthesizes 5 years of pivotal clinical and translational advances in esophageal cancer (EC), encompassing molecular pathogenesis, genomic and epigenetic landscapes, targeted therapeutic modalities and the tumor immune microenvironment. It underscores breakthroughs of immunotherapy in EC management while acknowledging slower progress in targeted treatments. Promising future directions include TKIs, CDK4/6 inhibitors, PI3K/AKT/mTOR pathway modulators, epigenetic regulators, ADCs, and rational combination strategies to overcome drug resistance and improve long-term patient survival outcomes.

BUFFALO, NY - October 14, 2026 – A new research paper was published in Volume 17 of Oncotarget on October 12, 2026, titled “Integrative pan-cancer analysis of AKT1 and structure-based drug design by buckwheat derived compounds.”

Many parents feel reassured when their child’s recurrent abdominal pain is investigated and no underlying organic condition is found. However, a study by researchers at Semmelweis University, published in the International Journal of Pediatrics, suggests that this may be when it is worth asking a few further questions: Does the child experience pain elsewhere in the body? Has the pain persisted for at least a year? If the answer to either question is yes, it may be a warning sign. 

Researchers created a nationwide pollution snapshot of 4 diamide insecticides (DAIs) across 47 cities and 9 major Chinese river basins. Cyantraniliprole (CYTP) was the most abundant, but broflanilide (BFA) produced the highest screening-level concern for benthic midges because its species-specific chronic threshold was lower. Crop-use patterns shaped regional composition patterns. Children’s modeled cumulative exposure from raw surface-water ingestion was 2.4 times the adults’ value, although all hazard quotients remained below 1.

Under universal health coverage, allocating antidepressant benefits requires balancing health costs, clinical efficacy, and patient financial protection. We propose a dual societal–household disease-burden optimization framework and a triple-population cooperative particle swarm algorithm. Validated on real-world data from City S, China, the optimized reimbursement package cuts household out-of-pocket spending by up to 48.97% per unit treatment effect, offering a transferable decision-support tool for mental health financing and health equity in low- and middle-income countries.

Wearable electronics are rapidly transforming healthcare by enabling continuous, real-time monitoring of physiological and molecular signals directly at the point of need. This shift supports a transition from episodic, generalized care toward precision diagnosis, where individualized, longitudinal data guide early detection, risk stratification, and treatment decisions. Central to this transformation is the convergence of advanced manufacturing and heterogeneous integration strategies, which enable the development of compact, multimodal, and highly conformable diagnostic platforms. In this review, we examine how advances in materials engineering, micro/nanofabrication, and system integration have transformed wearable devices from single-parameter sensors into fully integrated, multimodal diagnostic systems. We outline key architectures and transduction mechanisms and highlight manufacturing approaches such as printing, 3D fabrication, photolithography, and laser writing. We emphasize heterogeneous integration strategies that combine sensing, electronics, power, and communication into skin-conformal platforms for long-term use. These advances enable precision diagnostics through continuous monitoring, multimodal data fusion, and individualized baselines. We also outline key challenges to clinical translation and discuss future directions toward robust, scalable, and clinically actionable systems, providing a strategic outlook for next-generation wearable electronics in precision diagnosis.

A common asthma medication improves motor skills and muscle strength in children with congenital myopathies, a group of incurable muscle diseases. In a study, children receiving the drug were able to both walk and stand up more quickly.